Continuous Infusion or Subcutaneous Injection of Granulocyte-Macrophage Colony-Stimulating Factor: Increased Efficacy and Reduced Toxicity When Given Subcutaneously
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1996.502
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 1996
Authors
Publisher
Springer Science and Business Media LLC